Treatment-free remission after dasatinib in patients with chronic myeloid leukaemia in chronic phase with deep molecular response: Final 5-year analysis of DASFREE

1. Shah, N.P.
2. García-Gutiérrez, V.
3. Jiménez-Velasco, A.
4. Larson, S.M.
5. Saussele, S.
6. Rea, D.
7. Mahon, F.-X.
8. Levy, M.Y.
9. Gómez-Casares, M.T.
10. Mauro, M.J.
11. Sy, O.
12. Martin-Regueira, P.
13. Lipton, J.H.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1111/BJH.18883 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

• 

Data source: Scopus